EW: Summary for Edwards Lifesciences Corporatio - Yahoo Finance

UK Markets close in 3 hrs 9 mins

Edwards Lifesciences Corporation (EW)


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
97.96+0.19 (+0.19%)
At close: 4:01PM EDT
People also watch
BAXBCRCAHSTJBSX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close97.77
Open98.86
Bid96.96 x 200
Ask98.15 x 100
Day's range97.63 - 99.43
52-week range81.12 - 121.75
Volume2,004,360
Avg. volume2,217,625
Market cap20.69B
Beta0.81
PE ratio (TTM)37.53
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Medical Product Stocks Earnings on Apr 25: SYK, EW, LH
    Zacksyesterday

    Medical Product Stocks Earnings on Apr 25: SYK, EW, LH

    Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.

  • Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?
    Zacks5 days ago

    Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?

    Edward Lifesciences Corp. (EW) is scheduled to report first-quarter 2017 earnings results after market close on Apr 25.

  • Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
    PR Newswire6 days ago

    Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance

    IRVINE, Calif., April 19, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received FDA clearance for its HemoSphere advanced monitoring platform. This technology provides clinicians with exceptional clarity on a patient's hemodynamics, or the factors that manage blood flow, to help them make proactive, timely clinical decisions. It's also a scalable platform that can be tailored to meet the needs of each patient and clinician.